Imuracetam: Difference between revisions
Appearance
Content deleted Content added
Updating {{chembox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:W |
m corrected primes |
||
(15 intermediate revisions by 12 users not shown) | |||
Line 1: | Line 1: | ||
{{chembox |
{{chembox |
||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ImageSize = 140px |
| ImageSize = 140px |
||
| |
| PIN = ''N'',''N''′-Bis[(2-oxopyrrolidin-1-yl)methyl]urea |
||
| OtherNames = |
| OtherNames = |
||
| |
|Section1={{Chembox Identifiers |
||
⚫ | |||
⚫ | |||
| PubChem = 163319 |
| PubChem = 163319 |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
Line 17: | Line 18: | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = WMKONRFEZGAHTE-UHFFFAOYSA-N |
| StdInChIKey = WMKONRFEZGAHTE-UHFFFAOYSA-N |
||
| CASNo_Ref = {{cascite|correct|??}} |
|||
| CASNo =67542-41-0 |
| CASNo = 67542-41-0 |
||
| ATCCode_prefix = |
|||
| ChEMBL = 2106342 |
|||
| ATCCode_suffix = |
|||
| SMILES = O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2 |
| SMILES = O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2 |
||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
| C=11 | H=18 | N=4 | O=3 |
|||
| MolarMass = 254.286 g/mol |
|||
| Appearance = |
| Appearance = |
||
| Density = |
| Density = |
||
| |
| MeltingPtC = 184.5 |
||
| MeltingPt_ref= <ref name=Ganellin>{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 | vauthors = Ganellin CR, Triggle DJ | publisher = CRC Press | date = 1996}}</ref> |
|||
| BoilingPt = |
| BoilingPt = |
||
| Solubility = }} |
| Solubility = }} |
||
| |
|Section5={{Chembox Pharmacology |
||
| AdminRoutes = |
| AdminRoutes = |
||
| Bioavail = |
| Bioavail = |
||
Line 42: | Line 43: | ||
| Legal_AU = |
| Legal_AU = |
||
| Legal_CA = |
| Legal_CA = |
||
| |
| Pregnancy_category = |
||
| |
| Pregnancy_AU = |
||
| |
| Pregnancy_US = }} |
||
}} |
}} |
||
'''Imuracetam''' is a |
'''Imuracetam''' is a drug of the [[racetam]] family.<ref>{{cite journal | vauthors = Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG | title = Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. | journal = Pharmaceutical Chemistry Journal | date = February 1998 | volume = 32 | issue = 2 | pages = 55–8 | doi = 10.1007/BF02464161 | s2cid = 29810469 }}</ref> It was under development in the 1970s, but was never marketed.<ref name=Ganellin/> |
||
==References== |
==References== |
||
{{reflist}} |
|||
<references/> |
|||
{{Racetams}} |
{{Racetams}} |
||
Line 56: | Line 57: | ||
[[Category:Racetams]] |
[[Category:Racetams]] |
||
[[Category:Pyrrolidones]] |
[[Category:Pyrrolidones]] |
||
⚫ | |||
[[Category:Ureas]] |
[[Category:Ureas]] |
||
⚫ | |||
{{nervous-system-drug-stub}} |
{{nervous-system-drug-stub}} |